Head-To-Head Comparison: Organon & Co. (NYSE:OGN) versus Ryman Healthcare (OTCMKTS:RYHTY)

Organon & Co. (NYSE:OGN) and Ryman Healthcare (OTCMKTS:RYHTY) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations and profitability.

Profitability

This table compares Organon & Co. and Ryman Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Organon & Co.	3.99%	99.95%	6.22%
Ryman Healthcare	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent ratings for Organon & Co. and Ryman Healthcare, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organon & Co.	2	5	0	0	1.71
Ryman Healthcare	0	0	0	0	0.00

Organon & Co. presently has a consensus price target of $11.40, suggesting a potential downside of 15.15%. Given Organon & Co.’s stronger consensus rating and higher probable upside, equities analysts clearly believe Organon & Co. is more favorable than Ryman Healthcare.

Risk and Volatility

Organon & Co. has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500. Comparatively, Ryman Healthcare has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500.

Valuation and Earnings

This table compares Organon & Co. and Ryman Healthcare”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organon & Co.	$6.22 billion	0.57	$187.00 million	$0.93	14.45
Ryman Healthcare	$502.59 million	2.47	-$100.65 million	N/A	N/A

Organon & Co. has higher revenue and earnings than Ryman Healthcare.

Institutional & Insider Ownership

77.4% of Organon & Co. shares are owned by institutional investors. 1.6% of Organon & Co. shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Organon & Co. beats Ryman Healthcare on 10 of the 11 factors compared between the two stocks.

About Organon & Co.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

About Ryman Healthcare

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company's villages provide a range of retirement living and care options, such as independent townhouses and apartments, and serviced apartments, as well as a care center, which offers rest homes, hospitals, dementia-level care, and respite and day care services. Its villages also provide all-weather bowling green, indoor heated swimming pool and spa, gym, internal atrium, beauty and hair salons, library, dining area, bar, lounges, croquet laws, shops, and movie theatre facilities. The company owns and operates retirement village units and care units. The company was founded in 1984 and is based in Christchurch, New Zealand.